MPG.eBooks - Description: Adalimumab for adult patients with rheumatological disorders

Cover Image

Read Now

Adalimumab for adult patients with rheumatological disorders a review of clinical effectiveness

The objective of this report is to summarize the evidence regarding the comparative efficacy of ADA compared with other bDMARDs and tofacitinib in patients with rheumatological disorders

Bibliographic Details
Main Authors:	Subramonian, Anusree, Peprah, Kwakye (Author), Picheca, Lory (Author)
Corporate Author:	Canadian Agency for Drugs and Technologies in Health Rapid Response Service
Format:	eBook
Language:	English
Published:	Ottawa (ON) CADTH 2020, July 2020
Edition:	Version 2.0
Series:	CADTH rapid response report: summary with critical appraisal
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK564802
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa

Description
Summary:	The objective of this report is to summarize the evidence regarding the comparative efficacy of ADA compared with other bDMARDs and tofacitinib in patients with rheumatological disorders
Physical Description:	1 PDF file (43 pages) illustrations